In This Section


the transformative potential of biomarkers

August 23, 2022

Register for on demand viewing

Each person’s cancer has a unique pattern of biomarkers, making biomarker testing a critical part of diagnostics and treatment. This Forum will explore where and how biomarkers are changing cancer research and care to benefit patients with cancer.


Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine of USC, Los Angeles, California


Steven D. Averbuch, MD,  S.D. Averbuch Consulting, LLC, Princeton, New Jersey

George D. Demetri, MD, FAACR, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

Jill Feldman, AACR Scientist↔Survivor Program®, EGFR Resisters, Chicago, Illinois

Joshua LaBaer, MD, PhD, Arizona State University, Biodesign Institute, Tempe, Arizona

Laura van ‘t Veer, PhD, UCSF Hellen Diller Family Comprehensive Cancer Center, San Francisco, California

Program Agenda Speaker Bios

AACR Patient Advocate Forums

The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and health care communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public. 

Special thanks to our supporters

Bristol Myers Squibb
Pfizer Oncology